These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32608221)

  • 1. Changes of plasma Von Willebrand factor and Von Willebrand factor-cleaving protease levels in pregnancy-induced hypertension.
    Zhang TT; Yu ZK; Xiu CF; Bai YT; Peng M; Guo ZH
    J Biol Regul Homeost Agents; 2020; 34(3):1147-1152. PubMed ID: 32608221
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia.
    Molvarec A; Rigó J; Bõze T; Derzsy Z; Cervenak L; Makó V; Gombos T; Udvardy ML; Hársfalvi J; Prohászka Z
    Thromb Haemost; 2009 Feb; 101(2):305-11. PubMed ID: 19190814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of Von Willebrand factor and levels of VWF-cleaving protease (ADAMTS13) in preterm and full term neonates.
    Strauss T; Elisha N; Ravid B; Rosenberg N; Lubetsky A; Levy-Mendelovich S; Morag I; Nowak Göttl U; Kenet G
    Blood Cells Mol Dis; 2017 Sep; 67():14-17. PubMed ID: 28087247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of plasma von Willebrand factor level and von Willebrand factor-cleaving protease activity in patients with chronic renal diseases.
    Lu GY; Shen L; Wang ZY; Guo XF; Bai X; Su J; Ruan CG
    Chin Med J (Engl); 2008 Jan; 121(2):133-6. PubMed ID: 18272039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation.
    Reiter RA; Varadi K; Turecek PL; Jilma B; Knöbl P
    Thromb Haemost; 2005 Mar; 93(3):554-8. PubMed ID: 15735809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the von Willebrand Factor Plasma Concentration and Ultrasonographic Doppler Findings in Pregnancies Complicated by Hypertensive Disorders: A Pilot Study.
    Szpera-Gozdziewicz A; Gozdziewicz T; Boruczkowski M; Dworacki G; Breborowicz GH
    Gynecol Obstet Invest; 2018; 83(3):252-258. PubMed ID: 29621786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. von Willebrand Factor, ADAMTS13 Activity, and Decline in Kidney Function: A Population-Based Cohort Study.
    Sedaghat S; de Vries PS; Boender J; Sonneveld MA; Hoorn EJ; Hofman A; de Maat MP; Franco OH; Ikram MA; Leebeek FW; Dehghan A
    Am J Kidney Dis; 2016 Nov; 68(5):726-732. PubMed ID: 27497525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.
    Takaya H; Namisaki T; Kitade M; Kaji K; Nakanishi K; Tsuji Y; Shimozato N; Moriya K; Seki K; Sawada Y; Saikawa S; Sato S; Kawaratani H; Akahane T; Noguchi R; Matsumoto M; Yoshiji H
    BMC Gastroenterol; 2019 Oct; 19(1):167. PubMed ID: 31638892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma ADAMTS13, von Willebrand Factor (VWF), and VWF Propeptide Profiles in Patients With Connective Tissue Diseases and Antiphospholipid Syndrome.
    Habe K; Wada H; Matsumoto T; Ohishi K; Ikejiri M; Tsuda K; Kondo M; Kamimoto Y; Ikeda T; Katayama N; Mizutani H
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):622-630. PubMed ID: 26759371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the von Willebrand Factor-ADAMTS13 Ratio With Incident Cardiovascular Events in Patients With Peripheral Arterial Disease.
    Green D; Tian L; Greenland P; Liu K; Kibbe M; Tracy R; Shah S; Wilkins JT; Huffman MD; Liao Y; Lloyd Jones D; McDermott MM
    Clin Appl Thromb Hemost; 2017 Oct; 23(7):807-813. PubMed ID: 27317583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are increased levels of von Willebrand factor in chronic coronary heart disease caused by decrease in von Willebrand factor cleaving protease activity? A study by an immunoassay with antibody against intact bond 842Tyr-843Met of the von Willebrand factor protein.
    He S; Cao H; Magnusson CG; Eriksson-Berg M; Mehrkash M; Schenck-Gustafsson K; Blombäck M
    Thromb Res; 2001 Aug; 103(3):241-8. PubMed ID: 11672586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Willebrand Factor, ADAMTS13, and the Risk of Mortality: The Rotterdam Study.
    Sonneveld MA; Franco OH; Ikram MA; Hofman A; Kavousi M; de Maat MP; Leebeek FW
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2446-2451. PubMed ID: 27737864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased von Willebrand factor over decreased ADAMTS-13 activity is associated with poor prognosis in patients with advanced non-small-cell lung cancer.
    Guo R; Yang J; Liu X; Wu J; Chen Y
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balance between von Willebrand factor and ADAMTS13 following major partial hepatectomy.
    Groeneveld DJ; Alkozai EM; Adelmeijer J; Porte RJ; Lisman T
    Br J Surg; 2016 May; 103(6):735-743. PubMed ID: 27005894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease.
    Mannucci PM; Capoferri C; Canciani MT
    Br J Haematol; 2004 Jul; 126(2):213-8. PubMed ID: 15238142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels and activities of von Willebrand factor and metalloproteinase with thrombospondin type-1 motif, number 13 in inflammatory bowel diseases.
    Cibor D; Owczarek D; Butenas S; Salapa K; Mach T; Undas A
    World J Gastroenterol; 2017 Jul; 23(26):4796-4805. PubMed ID: 28765701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura.
    Yarranton H; Lawrie AS; Purdy G; Mackie IJ; Machin SJ
    Transfus Med; 2004 Feb; 14(1):39-44. PubMed ID: 15043592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of plasma von Willebrand factor-cleaving protease (ADAMTS13) antigen levels in patients with coronary artery disease.
    Miura M; Kaikita K; Matsukawa M; Soejima K; Fuchigami S; Miyazaki Y; Ono T; Uemura T; Tsujita K; Hokimoto S; Sumida H; Sugiyama S; Matsui K; Yamabe H; Ogawa H
    Thromb Haemost; 2010 Mar; 103(3):623-9. PubMed ID: 20135067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction.
    Matsukawa M; Kaikita K; Soejima K; Fuchigami S; Nakamura Y; Honda T; Tsujita K; Nagayoshi Y; Kojima S; Shimomura H; Sugiyama S; Fujimoto K; Yoshimura M; Nakagaki T; Ogawa H
    Am J Cardiol; 2007 Sep; 100(5):758-63. PubMed ID: 17719316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Von Willebrand factor and ADAMTS13 plasma in older patients with high CHA2DS2-VASc Score with and without atrial fibrillation.
    Zhang F; Yang XC; Jia XW; Tang XH; Wang Z; Wang ZQ
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4907-4912. PubMed ID: 29164570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.